Determinants of monovalent oral polio vaccine mutagenesis in vaccinated elderly people

Vaccine

Volumn 25, Issue 24, 2007, Pages 4706-4714

  Boot, Hein J ^a   Sonsma, Jan ^a   van Nunen, Femke ^a   Abbink, Frithjofna ^a   Kimman, Tjeerd G ^a   Buisman, Anne Marie ^a  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

Author keywords

Monovalent oral poliovirus vaccine; Mutation analysis; Vaccine derived poliovirus

Indexed keywords

EPITOPE; POLIOMYELITIS VACCINE;

ARTICLE; CONTROLLED STUDY; FECES; HUMAN; HUMAN TISSUE; IMMUNE STATUS; MOUSE; NONHUMAN; POLIOMYELITIS; PRIORITY JOURNAL; VACCINATION; VIRUS CAPSID; VIRUS MUTATION; VIRUS STRAIN;

AGED; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANIMALS; ANTIBODIES, VIRAL; CAPSID PROTEINS; DNA MUTATIONAL ANALYSIS; EPITOPES; FECES; GENOME, VIRAL; HUMANS; MICE; MICE, TRANSGENIC; MOLECULAR SEQUENCE DATA; MUTATION; NEUTRALIZATION TESTS; PHENOTYPE; POLIOVIRUS; POLIOVIRUS VACCINE, ORAL; RNA, VIRAL; VIRUS SHEDDING;

EID: 34248551257     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2007.04.007     Document Type: Article

References (24)

1. Abbink F., Buisman A.M., Doornbos G., Woldman J., Kimman T.G., and Conyn-van Spaendonck M.A. Poliovirus-specific memory immunity in seronegative elderly people does not protect against virus excretion. J Infect Dis 191 6 (2005) 990-999
2. Bijkerk H. The poliomyelitis outbreak in the Veluwe. Ned Tijdschr Geneeskd 122 24 (1978) 885-888
3. Boot H.J., Kasteel D.T., Buisman A.M., and Kimman T.G. Excretion of wild-type and vaccine-derived poliovirus in the feces of poliovirus receptor-transgenic mice. J Virol 77 11 (2003) 6541-6545
4. Boot H.J., Schepp R.M., van Nunen F.J., and Kimman T.G. Rapid RT-PCR amplification of full-length poliovirus genomes allows rapid discrimination between wild-type and recombinant vaccine-derived polioviruses. J Virol Meth 116 1 (2004) 35-43
5. Boot H.J., Lukashov V.V., van Remmerden Y., and Kimman T.G. Identification, phenotypic analysis, and full-length nucleotide sequence of a Dutch Coxsackievirus A20 isolate. Virus Genes 34 1 (2007) 75-85
6. Bouchard M.J., Lam D.H., and Racaniello V.R. Determinants of attenuation and temperature sensitivity in the type 1 poliovirus Sabin vaccine. J Virol 69 8 (1995) 4972-4978
7. Caceres V.M., and Sutter R.W. Sabin monovalent oral polio vaccines: review of past experiences and their potential use after polio eradication. Clin Infect Dis 33 4 (2001) 531-541
8. CDC. Brief report: conclusions and recommendations of the Advisory Committee on Poliomyelitis Eradication-Geneva, Switzerland, October 2005. MMWR Morb Mortal Wkly Rep 54 46 (2005) 1186-1188
9. CDC. Update on vaccine-derived polioviruses. MMRW 55 40 (2006) 1093-1097
10. Dowdle W., and Kew O. Vaccine-derived polioviruses: is it time to stop using the word "rare"?. J Infect Dis 194 5 (2006) 539-541
11. Heymann D.L., Sutter R.W., and Aylward R.B. A global call for new polio vaccines. Nature 434 7034 (2005) 699-700
12. Kew O., Morris-Glasgow V., Landaverde M., Burns C., Shaw J., Garib Z., et al. Outbreak of poliomyelitis in hispaniola associated with circulating type 1 vaccine-derived poliovirus. Science 296 5566 (2002) 356-359
13. Kew O.M., Wright P.F., Agol V.I., Delpeyroux F., Shimizu H., Nathanson N., et al. Circulating vaccine-derived polioviruses: current state of knowledge. Bull World Health Organ 82 1 (2004) 16-23
14. Laassri M., Lottenbach K., Belshe R., Wolff M., Rennels M., Plotkin S., et al. Effect of different vaccination schedules on excretion of oral poliovirus vaccine strains. J Infect Dis 192 12 (2005) 2092-2098
15. Malnou C.E., Werner A., Borman A.M., Westhof E., and Kean K.M. Effects of vaccine strain mutations in domain V of the internal ribosome entry segment compared in the wild type poliovirus type 1 context. J Biol Chem 279 11 (2004) 10261-10269
16. McGoldrick A., Macadam A.J., Dunn G., Rowe A., Burlison J., Minor P.D., et al. Role of mutations G-480 and C-6203 in the attenuation phenotype of Sabin type 1 poliovirus. J Virol 69 12 (1995) 7601-7605
17. Nakano J.H., Hatch M.H., Thieme M.L., and Nottay B. Parameters for differentiating vaccine-derived and wild poliovirus strains. Prog Med Virol 24 (1978) 178-206
18. Nkowane B.M., Wassilak S.G., Orenstein W.A., Bart K.J., Schonberger L.B., Hinman A.R., et al. Vaccine-associated paralytic poliomyelitis. United States: 1973 through. JAMA 257 10 (1987) 1335-1340
19. Onorato I.M., Modlin J.F., McBean A.M., Thoms M.L., Losonsky G.A., and Bernier R.H. Mucosal immunity induced by enhance-potency inactivated and oral polio vaccines. J Infect Dis 163 1 (1991) 1-6
20. Oostvogel P.M., van Wijngaarden J.K., van der Avoort H.G., Mulders M.N., Conyn-van Spaendonck M.A., Rumke H.C., et al. Poliomyelitis outbreak in an unvaccinated community in The Netherlands. Lancet 344 8923 (1994) 665-670
21. Schoub B.D., Johnson S., McAnerney J., Gilbertson L., Klaassen K.I., and Reinach S.G. Monovalent neonatal polio immunization-a strategy for the developing world. J Infect Dis 157 4 (1988) 836-839
22. Shimizu H., Thorley B., Paladin F.J., Brussen K.A., Stambos V., Yuen L., et al. Circulation of type 1 vaccine-derived poliovirus in the Philippines in 2001. J Virol 78 24 (2004) 13512-13521
23. WHO. Intratypic differentiation of polioviruses. Polio laboratory manual. 4th ed. (2004), WHO pp. 93-99
24. Yakovenko M.L., Cherkasova E.A., Rezapkin G.V., Ivanova O.E., Ivanov A.P., Eremeeva T.P., et al. Antigenic evolution of vaccine-derived polioviruses: changes in individual epitopes and relative stability of the overall immunological properties. J Virol 80 6 (2006) 2641-2653